Use of exenatide and liraglutide in Denmark: a drug utilization study

Anton Pottegård; Bine Kjøller Bjerregaard; Michael Due Larsen; Kasper Søltoft Larsen; Jesper Hallas; Filip K Knop; Søren Ilsøe Moreno

doi:10.1007/s00228-013-1595-4

Use of exenatide and liraglutide in Denmark: a drug utilization study

Anton Pottegård, Bine Kjøller Bjerregaard, Michael Due Larsen, Kasper Søltoft Larsen, Jesper Hallas, Filip K Knop, Søren Ilsøe Moreno

13 Citations (Scopus)

Abstract

The purpose of this study was to characterise the utilization of the glucagon-like peptide-1 (GLP-1) analogues exenatide and liraglutide in Denmark.

Original language	English
Journal	European Journal of Clinical Pharmacology
Volume	70
Issue number	2
Pages (from-to)	205-214
Number of pages	10
ISSN	0031-6970
DOIs	https://doi.org/10.1007/s00228-013-1595-4
Publication status	Published - Feb 2014

Access to Document

10.1007/s00228-013-1595-4

Cite this

@article{49779329052f44fc92d68b41a3c5b560,

title = "Use of exenatide and liraglutide in Denmark: a drug utilization study",

abstract = "The purpose of this study was to characterise the utilization of the glucagon-like peptide-1 (GLP-1) analogues exenatide and liraglutide in Denmark.",

author = "Anton Potteg{\aa}rd and Bjerregaard, \{Bine Kj{\o}ller\} and Larsen, \{Michael Due\} and Larsen, \{Kasper S{\o}ltoft\} and Jesper Hallas and Knop, \{Filip K\} and Moreno, \{S{\o}ren Ils{\o}e\}",

year = "2014",

month = feb,

doi = "10.1007/s00228-013-1595-4",

language = "English",

volume = "70",

pages = "205--214",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "2",

}

TY - JOUR

T1 - Use of exenatide and liraglutide in Denmark

T2 - a drug utilization study

AU - Pottegård, Anton

AU - Bjerregaard, Bine Kjøller

AU - Larsen, Michael Due

AU - Larsen, Kasper Søltoft

AU - Hallas, Jesper

AU - Knop, Filip K

AU - Moreno, Søren Ilsøe

PY - 2014/2

Y1 - 2014/2

N2 - The purpose of this study was to characterise the utilization of the glucagon-like peptide-1 (GLP-1) analogues exenatide and liraglutide in Denmark.

AB - The purpose of this study was to characterise the utilization of the glucagon-like peptide-1 (GLP-1) analogues exenatide and liraglutide in Denmark.

UR - https://www.scopus.com/pages/publications/84895074422

U2 - 10.1007/s00228-013-1595-4

DO - 10.1007/s00228-013-1595-4

M3 - Journal article

C2 - 24145815

SN - 0031-6970

VL - 70

SP - 205

EP - 214

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

IS - 2

ER -

Use of exenatide and liraglutide in Denmark: a drug utilization study

Abstract

Access to Document

Other files and links

Fingerprint

Cite this